Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Immuneering Corp as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +4 vs. Q1 2025
- Shares held
- 3.83M
- −668.9K (−14.9%) vs. Q1 2025
- Total value
- $12.9M
- +$6.07M (+88.8%) vs. Q1 2025
- New holders
- 11
- 8 more added
- Sold out
- 7
- 6 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,056,922 | $3.56M | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 573,864 | $1.93M | 0.00% | −234,105−29.0% | Reduced |
| BlackRock, Inc. | 422,758 | $1.42M | 0.00% | +106,228+33.6% | Added |
| Southport Management, L.L.C. | 245,000 | $825.6K | 4.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 230,275 | $776.2K | 0.00% | +4,458+2.0% | Added |
| FMR LLC | 221,000 | $744.8K | 0.00% | +221,000 | New |
| Morgan Stanley | 201,094 | $677.7K | 0.00% | −266,132−57.0% | Reduced |
| HighTower Advisors, LLC | 135,960 | $458.2K | 0.00% | +52,000+61.9% | Added |
| State Street Corp | 97,335 | $328.0K | 0.00% | +18,800+23.9% | Added |
| Bridgeway Capital Management, LLC | 95,449 | $321.7K | 0.01% | +35,000+57.9% | Added |
| CI Private Wealth, LLC | 63,740 | $214.8K | 0.00% | +63,740 | New |
| Millennium Management LLC | 62,249 | $209.8K | 0.00% | +39,184+169.9% | Added |
| Tidemark, LLC | 44,400 | $149.6K | 0.05% | 00.0% | Unchanged |
| Northern Trust Corp | 39,729 | $133.9K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 32,325 | $108.9K | 0.00% | 00.0% | Unchanged |
| Flower City Capital | 32,029 | $107.9K | 0.06% | +32,029 | New |
| Cubist Systematic Strategies, LLC | 29,404 | $99.1K | 0.00% | +29,404 | New |
| Bank of America Corp | 28,492 | $96.0K | 0.00% | −362−1.3% | Reduced |
| XTX Topco Ltd | 26,829 | $90.4K | 0.00% | +26,829 | New |
| Alethea Capital Management, LLC | 22,935 | $77.3K | 0.06% | +22,935 | New |
| Royal Bank of Canada | 20,960 | $71.0K | 0.00% | +20,959+2,095,900.0% | Added |
| The PNC Financial Services Group, Inc. | 20,000 | $67.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 18,553 | $62.5K | 0.00% | −17,204−48.1% | Reduced |
| Renaissance Technologies LLC | 18,200 | $61.3K | 0.00% | +18,200 | New |
| CIBC Private Wealth Group, LLC | 15,000 | $50.5K | 0.00% | +5,000+50.0% | Added |
| Kingsview Wealth Management, LLC | 14,000 | $47.2K | 0.00% | +14,000 | New |
| Dimensional Fund Advisors LP | 13,366 | $45.2K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 12,000 | $40.4K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,000 | $33.7K | 0.00% | +10,000 | New |
| Barclays PLC | 9,924 | $33.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,073 | $17.1K | 0.00% | −23,478−82.2% | Reduced |
| Advisor Group Holdings, Inc. | 4,300 | $14.5K | 0.00% | +4,300 | New |
| Tower Research Capital LLC (TRC) | 2,984 | $10.1K | 0.00% | −3,344−52.8% | Reduced |
| JPMorgan Chase & Co | 1,974 | $6.65K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 796 | $2.68K | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 345 | $1.16K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 287 | $967 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 74 | $249 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 16 | $54 | 0.00% | +16 | New |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −659,009−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −82,667−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −71,066−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,869−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,607−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −3,954−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −228−100.0% | Sold out |